News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2022 Caitlin E. Cox December 01, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
Presentation ESC 2022 International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up Presenter: Sripal Bangalore August 29, 2022
News Conference News SCAI 2022 Cocaine History? For Black Patients It Means Less Chance of Revascularization L.A. McKeown May 26, 2022